Uterine corpus adenosarcoma

MONDO:0002878

A primary polypoid malignant neoplasm of the uterine corpus characterized by the presence of a sarcomatous mesenchymal component and a benign epithelial component. Patients usually present with abnormal vaginal bleeding. It is considered a low grade malignant neoplasm and may recur following resection.

Also known as: adenosarcoma of body of uterus, adenosarcoma of the body of uterus, adenosarcoma of the corpus uteri, adenosarcoma of the uterine body, adenosarcoma of the uterine corpus, adenosarcoma of uterine body, adenosarcoma of uterine corpus, body of uterus adenosarcoma

2841 clinical trials for this condition and its sub-types, 1 tagged with Uterine corpus adenosarcoma itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Uterine body mixed cancer (14) ↑ Adenosarcoma (2)

Including sub-types (2841) Tagged with Uterine corpus adenosarcoma (1)

Trials to join now! 1

Could a pill that blocks estrogen help fight rare uterine cancers?

Disease control Recruiting now

This phase 2 trial is testing elacestrant, a pill that breaks down estrogen receptors, in 30 people with advanced uterine sarcomas that are fueled by estrogen. The goal is to see if the drug can shrink tumors or slow their growth. Participants must have tumors that strongly expre…

Phase 2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

Uterine corpus adenosarcoma

Where it sits in the disease tree

Could a pill that blocks estrogen help fight rare uterine cancers?